Clyde Hosein
Analyst · Citigroup
Thank you, Sehat, and good afternoon, everyone. As Sehat mentioned, fiscal Q1 revenues came in at approximately $856 million, representing a 2% sequential increase over fiscal Q4 2010 and an increase of 64% in the same period a year ago. Our overall revenue performance came in at the higher end of our guidance. Our non-GAAP gross margin for the first quarter was approximately 60.6%, up 60 basis points from the fourth quarter and up about 900 basis points from the same period a year ago. This was slightly better than our initial guidance of 60% plus or minus 50 basis points. Our overall operating expenses for the first quarter on a non-GAAP basis were approximately $255 million, in line with our earlier projected range of $250 million to $260 million. As compared to the same period a year ago, operating expenses were up approximately 9%, while revenues grew 64%, demonstrating the leverage in our business model. R&D expenses for the quarter were approximately $200 million, an increase of 7% on a sequential basis and an increase of about 12% from the same period a year ago. This was in line with the midpoint of our original guidance of $203 million. SG&A expenses for the quarter were approximately $55 million, an increase of 8% sequentially and a decrease of approximately 2% from the year-ago period. This was slightly above the midpoint of our prior guidance of $52 million. The sequential increase in operating expense was a result of higher legal expenses, higher employee-related costs and new product introductions. This resulted in non-GAAP operating margin of approximately 30.7%, down about 100 basis points from the 31.7% operating margin reported in the prior quarter, an improvement of about 24 points from the same period a year ago. Net interest expense and other income was an expense of approximately $3.8 million. This was lower than our original target, primarily due to foreign exchange effects and our tax accrual accounts. On a non-GAAP basis, we realized a tax benefit of approximately $1 million, better than our prior guidance of the $2 million expense. Our non-GAAP net income for the first quarter was approximately $260 million or $0.38 per diluted share, a sequential decrease of $0.02 per share. During the same period a year ago, we earned $32 million or $0.05 per share. The shares used to compute diluted non-GAAP EPS during the first quarter were approximately 681 million, up from 672 million shares in the prior quarter and higher than the 637 million shares reported in the year-ago period. Let me now summarize our Q1 results on a GAAP basis. We generated GAAP net income of approximately $206 million or $0.30 per share in the first quarter, essentially flat with the $205 million or $0.31 per share in the prior quarter and better than the $0.18 per share loss we reported in the same period a year ago. The difference between our GAAP and non-GAAP results during the first quarter of fiscal 2011 was due to stock-based compensation expense of approximately $27 million or about $0.04 per diluted share, amortization of intangibles representing approximately $23 million or about $0.03 per diluted share and approximately $4 million or $0.01 per diluted share representing the historical portion of a settlement related to an IP infringement lawsuit. Now, I'd like to review our balance sheet as of the end of our first quarter. Cash and short-term investments were approximately $2.1 billion, up about $282 million sequentially and up approximately $1 billion from the same period a year ago. Cash flow from operations for the first quarter was approximately $256 million, as compared to $281 million reported in the fourth quarter and up from the $145 million reported in the same period a year ago. Free cash flow for the first quarter was approximately $237 million, representing a 28% free cash flow margin, down 6% on a sequential basis and an 80% improvement from the $132 million in free cash flow reported in the year-ago period. Accounts receivable was approximately $449 million, up about $92 million sequentially, reflecting increased shipment later in the quarter and up $163 million as compared to the same period a year ago. DSO was 43 days, up about two days sequentially and down just over a day from the same period a year ago and in line on the low side of historical norms. Net inventory at the end of the first quarter were approximately $207 million, down 14% from the $242 million reported in the fourth quarter. Net inventories increased $3 million or 1% on a year-on-year basis. Days of inventory were about 59 days, down five days sequentially from the 64 days reported in the previous quarter and down 31 days from the year-ago period. We continue to run with lean inventory, despite our efforts to increase our inventory position and improve our customer serviceability. However, tightness in our supply chain, combined with robust demand for our new products, continued to put pressure on our inventory position. We expect that situation to continue into Q2. Accounts payable were $289 million, up about $11 million sequentially and up $122 million on a year-on-year basis. Now, I'd like to turn to our expectations for the second fiscal quarter of 2011. We currently project second quarter revenues in the range of $900 million to $930 million, a sequential increase of 5% to 9%. As I have indicated, the growth we experienced in the last quarter, and expect to continue into this quarter, is a lesser function of end market growth but rather due to new products and customers, resulting in share gains from the investments we have made in the past. We continue to monitor the end markets. And we'll put our customers to manage inventory, cautious about any channel inventory build. We currently project non-GAAP gross margin in a range of 59% to 60%, in line with our long-term model, but reflecting a modest downward bias at the midpoint due to accommodation of product mix and the potential for margin compression due to tighter supply constraints. We currently anticipate non-GAAP operating expenses to be approximately $265 million plus or minus $5 million. At the midpoint, we anticipate R&D expenses to be approximately $210 million and SG&A expenses of approximately $55 million. As we get more comfortable with revenue growth from the new products, we'll continue to make the necessary investment to support our anticipated growth while maintaining our best-in-class margins. The primary drivers of the sequential increase in operating expenses, additional new hires, salary and benefit related-expenses and increased new product introduction expense. At the midpoint of our range, our guidance should translate into an operating margin of approximately 31%, plus or minus about a point. The combination of interest expense and other income together should net out to be approximately $1 million benefit. Non-GAAP tax expense should be approximately $3 million to $5 million. We currently believe that diluted share count will be approximately 688 million shares and project non-GAAP EPS to be in the range of $0.38 to $0.43 per share. On the balance sheet, we currently expect to generate approximately $270 million in free cash flow during the quarter. We anticipate our cash balance to be about $2.35 billion, excluding any special items or M&A activity. We currently expect our GAAP EPS to be lower than our non-GAAP EPS by about $0.07 per share, plus or minus $0.01. About $0.03 of this difference is related to amortization of intangibles and $0.04 of stock-based compensation expense. Now I'd like to turn the call over to the operator to begin the Q&A portion of the call. Keana?